Compare HCSG & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCSG | SDGR |
|---|---|---|
| Founded | 1976 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Assisted Living Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1994 | 2020 |
| Metric | HCSG | SDGR |
|---|---|---|
| Price | $20.58 | $30.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $27.00 | $21.43 |
| AVG Volume (30 Days) | 525.9K | ★ 2.0M |
| Earning Date | 10-21-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.83 | 45.14 |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $1,837,173,000.00 | $255,869,000.00 |
| Revenue This Year | $4.26 | N/A |
| Revenue Next Year | $6.17 | $3.12 |
| P/E Ratio | $30.22 | ★ N/A |
| Revenue Growth | 7.08 | ★ 23.29 |
| 52 Week Low | $15.26 | $10.95 |
| 52 Week High | $25.75 | $31.59 |
| Indicator | HCSG | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 33.03 | 73.76 |
| Support Level | $20.01 | $11.27 |
| Resistance Level | $21.24 | $31.59 |
| Average True Range (ATR) | 0.45 | 2.33 |
| MACD | -0.08 | 0.28 |
| Stochastic Oscillator | 14.75 | 90.69 |
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company manages and evaluates its operations in two reportable segments: Environmental Services segment includes housekeeping, management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services, linen and other services; and Dietary Segment includes dietary department services, food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America. The Environmental Services segment derives maximum revenue.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.